OBJECTIVES: This study sought to ascertain the relationship of 9p21 locus with: 1) angiographic coronary artery disease (CAD) burden; and 2) myocardial infarction (MI) in individuals with underlying CAD. BACKGROUND: Chromosome 9p21 variants have been robustly associated with coronary heart disease, but questions remain on the mechanism of risk, specifically whether the locus contributes to coronary atheroma burden or plaque instability. METHODS: We established a collaboration of 21 studies consisting of 33,673 subjects with information on both CAD (clinical or angiographic) and MI status along with 9p21 genotype. Tabular data are provided for each cohort on the presence and burden of angiographic CAD, MI cases with underlying CAD, and the diabetic status of all subjects. RESULTS: We first confirmed an association between 9p21 and CAD with angiographically defined cases and control subjects (pooled odds ratio [OR]: 1.31, 95% confidence interval [CI]: 1.20 to 1.43). Among subjects with angiographic CAD (n = 20,987), random-effects model identified an association with multivessel CAD, compared with those with single-vessel disease (OR: 1.10, 95% CI: 1.04 to 1.17)/copy of risk allele). Genotypic models showed an OR of 1.15, 95% CI: 1.04 to 1.26 for heterozygous carrier and OR: 1.23, 95% CI: 1.08 to 1.39 for homozygous carrier. Finally, there was no significant association between 9p21 and prevalent MI when both cases (n = 17,791) and control subjects (n = 15,882) had underlying CAD (OR: 0.99, 95% CI: 0.95 to 1.03)/risk allele. CONCLUSIONS: The 9p21 locus shows convincing association with greater burden of CAD but not with MI in the presence of underlying CAD. This adds further weight to the hypothesis that 9p21 locus primarily mediates an atherosclerotic phenotype.
OBJECTIVES: This study sought to ascertain the relationship of 9p21 locus with: 1) angiographic coronary artery disease (CAD) burden; and 2) myocardial infarction (MI) in individuals with underlying CAD. BACKGROUND: Chromosome 9p21 variants have been robustly associated with coronary heart disease, but questions remain on the mechanism of risk, specifically whether the locus contributes to coronary atheroma burden or plaque instability. METHODS: We established a collaboration of 21 studies consisting of 33,673 subjects with information on both CAD (clinical or angiographic) and MI status along with 9p21 genotype. Tabular data are provided for each cohort on the presence and burden of angiographic CAD, MI cases with underlying CAD, and the diabetic status of all subjects. RESULTS: We first confirmed an association between 9p21 and CAD with angiographically defined cases and control subjects (pooled odds ratio [OR]: 1.31, 95% confidence interval [CI]: 1.20 to 1.43). Among subjects with angiographic CAD (n = 20,987), random-effects model identified an association with multivessel CAD, compared with those with single-vessel disease (OR: 1.10, 95% CI: 1.04 to 1.17)/copy of risk allele). Genotypic models showed an OR of 1.15, 95% CI: 1.04 to 1.26 for heterozygous carrier and OR: 1.23, 95% CI: 1.08 to 1.39 for homozygous carrier. Finally, there was no significant association between 9p21 and prevalent MI when both cases (n = 17,791) and control subjects (n = 15,882) had underlying CAD (OR: 0.99, 95% CI: 0.95 to 1.03)/risk allele. CONCLUSIONS: The 9p21 locus shows convincing association with greater burden of CAD but not with MI in the presence of underlying CAD. This adds further weight to the hypothesis that 9p21 locus primarily mediates an atherosclerotic phenotype.
Authors: Christopher J O'Donnell; Maryam Kavousi; Albert V Smith; Sharon L R Kardia; Mary F Feitosa; Shih-Jen Hwang; Yan V Sun; Michael A Province; Thor Aspelund; Abbas Dehghan; Udo Hoffmann; Lawrence F Bielak; Qunyuan Zhang; Gudny Eiriksdottir; Cornelia M van Duijn; Caroline S Fox; Mariza de Andrade; Aldi T Kraja; Sigurdur Sigurdsson; Suzette E Elias-Smale; Joanne M Murabito; Lenore J Launer; Aad van der Lugt; Sekar Kathiresan; Gabriel P Krestin; David M Herrington; Timothy D Howard; Yongmei Liu; Wendy Post; Braxton D Mitchell; Jeffrey R O'Connell; Haiqing Shen; Alan R Shuldiner; David Altshuler; Roberto Elosua; Veikko Salomaa; Stephen M Schwartz; David S Siscovick; Benjamin F Voight; Joshua C Bis; Nicole L Glazer; Bruce M Psaty; Eric Boerwinkle; Gerardo Heiss; Stefan Blankenberg; Tanja Zeller; Philipp S Wild; Renate B Schnabel; Arne Schillert; Andreas Ziegler; Thomas F Münzel; Charles C White; Jerome I Rotter; Michael Nalls; Matthijs Oudkerk; Andrew D Johnson; Anne B Newman; Andre G Uitterlinden; Joseph M Massaro; Julie Cunningham; Tamara B Harris; Albert Hofman; Patricia A Peyser; Ingrid B Borecki; L Adrienne Cupples; Vilmundur Gudnason; Jacqueline C M Witteman Journal: Circulation Date: 2011-12-05 Impact factor: 29.690
Authors: Sonny Dandona; Alexandre F R Stewart; Li Chen; Kathryn Williams; Derek So; Ed O'Brien; Christopher Glover; Michel Lemay; Olivia Assogba; Lan Vo; Yan Qing Wang; Marino Labinaz; George A Wells; Ruth McPherson; Robert Roberts Journal: J Am Coll Cardiol Date: 2010-08-03 Impact factor: 24.094
Authors: Axel Visel; Yiwen Zhu; Dalit May; Veena Afzal; Elaine Gong; Catia Attanasio; Matthew J Blow; Jonathan C Cohen; Edward M Rubin; Len A Pennacchio Journal: Nature Date: 2010-02-21 Impact factor: 49.962
Authors: Themistocles L Assimes; Joshua W Knowles; Analabha Basu; Carlos Iribarren; Audrey Southwick; Hua Tang; Devin Absher; Jun Li; Joan M Fair; Geoffrey D Rubin; Stephen Sidney; Stephen P Fortmann; Alan S Go; Mark A Hlatky; Richard M Myers; Neil Risch; Thomas Quertermous Journal: Hum Mol Genet Date: 2008-04-28 Impact factor: 6.150
Authors: Christie Cluett; Mary McGrae McDermott; Jack Guralnik; Luigi Ferrucci; Stefania Bandinelli; Iva Miljkovic; Joseph M Zmuda; Rongling Li; Greg Tranah; Tamara Harris; Neil Rice; William Henley; Timothy M Frayling; Anna Murray; David Melzer Journal: Circ Cardiovasc Genet Date: 2009-06-23
Authors: Anna Motterle; Xiangyuan Pu; Harriet Wood; Qingzhong Xiao; Shivani Gor; Fu Liang Ng; Kenneth Chan; Frank Cross; Beski Shohreh; Robin N Poston; Arthur T Tucker; Mark J Caulfield; Shu Ye Journal: Hum Mol Genet Date: 2012-06-15 Impact factor: 6.150
Authors: Christopher J O'Donnell; L Adrienne Cupples; Ralph B D'Agostino; Caroline S Fox; Udo Hoffmann; Shih-Jen Hwang; Erik Ingellson; Chunyu Liu; Joanne M Murabito; Joseph F Polak; Philip A Wolf; Serkalem Demissie Journal: BMC Med Genet Date: 2007-09-19 Impact factor: 2.103
Authors: Aaron R Folsom; James S Pankow; Xiaohui Li; Daniel A Duprez; David R Jacobs; Ronald Klein; Barbara Klein; Weihong Tang; Tien Yin Wong; Mary Frances Cotch; Kent D Taylor; Stephen S Rich; Jennifer L Hall; Wendy S Post; Jerome I Rotter Journal: Atherosclerosis Date: 2013-08-02 Impact factor: 5.162
Authors: Ivan Zivotić; Tamara Djurić; Aleksandra Stanković; Ana Djordjević; Igor Končar; Lazar Davidović; Dragan Alavantić; Maja Zivković Journal: Exp Biol Med (Maywood) Date: 2016-03-03
Authors: Stephen Zewinger; Marcus E Kleber; Vinicius Tragante; Raymond O McCubrey; Amand F Schmidt; Kenan Direk; Ulrich Laufs; Christian Werner; Wolfgang Koenig; Dietrich Rothenbacher; Ute Mons; Lutz P Breitling; Herrmann Brenner; Richard T Jennings; Ioannis Petrakis; Sarah Triem; Mira Klug; Alexandra Filips; Stefan Blankenberg; Christoph Waldeyer; Christoph Sinning; Renate B Schnabel; Karl J Lackner; Efthymia Vlachopoulou; Ottar Nygård; Gard Frodahl Tveitevåg Svingen; Eva Ringdal Pedersen; Grethe S Tell; Juha Sinisalo; Markku S Nieminen; Reijo Laaksonen; Stella Trompet; Roelof A J Smit; Naveed Sattar; J Wouter Jukema; Heinrich V Groesdonk; Graciela Delgado; Tatjana Stojakovic; Anna P Pilbrow; Vicky A Cameron; A Mark Richards; Robert N Doughty; Yan Gong; Rhonda Cooper-DeHoff; Julie Johnson; Markus Scholz; Frank Beutner; Joachim Thiery; J Gustav Smith; Ragnar O Vilmundarson; Ruth McPherson; Alexandre F R Stewart; Sharon Cresci; Petra A Lenzini; John A Spertus; Oliviero Olivieri; Domenico Girelli; Nicola I Martinelli; Andreas Leiherer; Christoph H Saely; Heinz Drexel; Axel Mündlein; Peter S Braund; Christopher P Nelson; Nilesh J Samani; Daniel Kofink; Imo E Hoefer; Gerard Pasterkamp; Arshed A Quyyumi; Yi-An Ko; Jaana A Hartiala; Hooman Allayee; W H Wilson Tang; Stanley L Hazen; Niclas Eriksson; Claes Held; Emil Hagström; Lars Wallentin; Axel Åkerblom; Agneta Siegbahn; Igor Karp; Christopher Labos; Louise Pilote; James C Engert; James M Brophy; George Thanassoulis; Peter Bogaty; Wojciech Szczeklik; Marcin Kaczor; Marek Sanak; Salim S Virani; Christie M Ballantyne; Vei-Vei Lee; Eric Boerwinkle; Michael V Holmes; Benjamin D Horne; Aroon Hingorani; Folkert W Asselbergs; Riyaz S Patel; Bernhard K Krämer; Hubert Scharnagl; Danilo Fliser; Winfried März; Thimoteus Speer Journal: Lancet Diabetes Endocrinol Date: 2017-05-26 Impact factor: 32.069